166 related articles for article (PubMed ID: 31792043)
1. Molecular regulation of Snai2 in development and disease.
Zhou W; Gross KM; Kuperwasser C
J Cell Sci; 2019 Dec; 132(23):. PubMed ID: 31792043
[TBL] [Abstract][Full Text] [Related]
2. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
3. Negative feedback by SNAI2 regulates TGFβ1-induced amelotin gene transcription in epithelial-mesenchymal transition.
Nakayama Y; Tsuruya Y; Noda K; Yamazaki-Takai M; Iwai Y; Ganss B; Ogata Y
J Cell Physiol; 2019 Jul; 234(7):11474-11489. PubMed ID: 30488439
[TBL] [Abstract][Full Text] [Related]
4. Snai2 Maintains Bone Marrow Niche Cells by Repressing Osteopontin Expression.
Wei Q; Nakahara F; Asada N; Zhang D; Gao X; Xu C; Alfieri A; Brodin NP; Zimmerman SE; Mar JC; Guha C; Guo W; Frenette PS
Dev Cell; 2020 Jun; 53(5):503-513.e5. PubMed ID: 32413329
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism involved in epithelial to mesenchymal transition.
Jayachandran J; Srinivasan H; Mani KP
Arch Biochem Biophys; 2021 Oct; 710():108984. PubMed ID: 34252392
[TBL] [Abstract][Full Text] [Related]
6. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
7. SNAI2 controls the undifferentiated state of human epidermal progenitor cells.
Mistry DS; Chen Y; Wang Y; Zhang K; Sen GL
Stem Cells; 2014 Dec; 32(12):3209-18. PubMed ID: 25100569
[TBL] [Abstract][Full Text] [Related]
8. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
9. [SNAI1 and SNAI2 - transcriptional master-regulators of epithelial-mesenchimal transition].
Usova EV; Kopantseva MR; Egorov VI; Kopantzev EP; Sverdlov ED
Patol Fiziol Eksp Ter; 2015; 59(2):76-87. PubMed ID: 26571812
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish snai2 mutants fail to phenocopy morphant phenotypes.
Bickers C; Española SD; Grainger S; Pouget C; Traver D
PLoS One; 2018; 13(9):e0202747. PubMed ID: 30208064
[TBL] [Abstract][Full Text] [Related]
11. 'Snail factors in testicular germ cell tumours and their regulation by the BMP4 signalling pathway'.
Micati DJ; Radhakrishnan K; Young JC; Rajpert-De Meyts E; Hime GR; Abud HE; Loveland KL
Andrology; 2020 Sep; 8(5):1456-1470. PubMed ID: 32441446
[TBL] [Abstract][Full Text] [Related]
12. Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.
Gao D; Wang L; Zhang H; Yan X; Yang J; Zhou R; Chang X; Sun Y; Tian S; Yao Z; Zhang K; Liu Z; Ma Z
FEBS J; 2018 Nov; 285(22):4229-4245. PubMed ID: 30251328
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells.
Zhao XY; Li L; Wang XB; Fu RJ; Lv YP; Jin W; Meng C; Chen GQ; Huang L; Zhao KW
PLoS One; 2016; 11(10):e0164752. PubMed ID: 27760172
[TBL] [Abstract][Full Text] [Related]
15. SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p-EMT.
Shang Q; Peng J; Jiang Y; Qing M; Zhou Y; Xu H; Chen Q
Oral Dis; 2023 Nov; 29(8):3232-3242. PubMed ID: 35894087
[TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
17. Keratin 13 gene is epigenetically suppressed during transforming growth factor-β1-induced epithelial-mesenchymal transition in a human keratinocyte cell line.
Hatta M; Miyake Y; Uchida K; Yamazaki J
Biochem Biophys Res Commun; 2018 Feb; 496(2):381-386. PubMed ID: 29326042
[TBL] [Abstract][Full Text] [Related]
18. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
Wang L; Jia Y; Jiang Z; Gao W; Wang B
Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
[TBL] [Abstract][Full Text] [Related]
19. CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.
Chung MK; Jung YH; Lee JK; Cho SY; Murillo-Sauca O; Uppaluri R; Shin JH; Sunwoo JB
Clin Cancer Res; 2018 Feb; 24(3):674-683. PubMed ID: 29208672
[No Abstract] [Full Text] [Related]
20. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
